share_log

David Largey Sells 5,000 Shares of SunOpta Inc. (NASDAQ:STKL) Stock

Defense World ·  Sep 15, 2022 05:41

SunOpta Inc. (NASDAQ:STKL – Get Rating) (TSE:SOY) insider David Largey sold 5,000 shares of the firm's stock in a transaction dated Monday, September 12th. The shares were sold at an average price of $10.05, for a total transaction of $50,250.00. Following the completion of the sale, the insider now owns 52,828 shares of the company's stock, valued at approximately $530,921.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

SunOpta Price Performance

NASDAQ STKL opened at $10.50 on Thursday. The company has a debt-to-equity ratio of 0.87, a current ratio of 2.18 and a quick ratio of 0.70. SunOpta Inc. has a fifty-two week low of $4.22 and a fifty-two week high of $11.47. The business has a fifty day moving average of $9.56 and a 200-day moving average of $7.42.

Get SunOpta alerts:

Institutional Trading of SunOpta

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in STKL. State Street Corp boosted its stake in shares of SunOpta by 4.4% during the 1st quarter. State Street Corp now owns 36,947 shares of the company's stock worth $185,000 after purchasing an additional 1,572 shares during the last quarter. Ironwood Investment Management LLC boosted its position in SunOpta by 1.5% during the first quarter. Ironwood Investment Management LLC now owns 152,455 shares of the company's stock worth $765,000 after acquiring an additional 2,325 shares during the last quarter. PNC Financial Services Group Inc. grew its stake in SunOpta by 81.7% in the 1st quarter. PNC Financial Services Group Inc. now owns 5,200 shares of the company's stock worth $26,000 after acquiring an additional 2,338 shares during the period. Cornerstone Capital Inc. raised its holdings in SunOpta by 23.7% in the 4th quarter. Cornerstone Capital Inc. now owns 13,580 shares of the company's stock valued at $94,000 after acquiring an additional 2,600 shares during the last quarter. Finally, Hodges Capital Management Inc. lifted its stake in shares of SunOpta by 0.9% during the 2nd quarter. Hodges Capital Management Inc. now owns 287,800 shares of the company's stock worth $2,239,000 after purchasing an additional 2,654 shares during the period. Hedge funds and other institutional investors own 79.57% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the company. Cowen raised their price target on SunOpta to $15.00 in a report on Monday, August 15th. Canaccord Genuity Group upped their price target on shares of SunOpta from $12.00 to $14.00 in a research note on Friday, August 12th. Craig Hallum increased their target price on shares of SunOpta to $18.00 in a report on Monday, August 15th. Finally, StockNews.com upgraded shares of SunOpta from a "sell" rating to a "hold" rating in a research report on Wednesday, August 24th.

About SunOpta

(Get Rating)

SunOpta Inc manufactures and sells plant-based and fruit-based food and beverage products to retail customers, foodservice distributors, branded food companies, and food manufacturers worldwide. The company operates through two segments, Plant-Based Foods and Beverages, and Fruit-Based Foods and Beverages.

Featured Stories

  • Get a free copy of the StockNews.com research report on SunOpta (STKL)
  • Is This Medical Gear Maker Ready To Continue Its Rally?
  • The Five (5) Hottest Stocks To Watch Ahead Of Q3 Earnings
  • Has Take-Two Interactive Devolved into a One-Trick Pony?
  • Four Cheap Stocks With Interesting Insider Activity
  • Can Health Drink Maker Celsius Outrun Its Monster Rival?

Receive News & Ratings for SunOpta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SunOpta and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment